Introduction {#Sec1}
============

Oxidative stress may induce DNA damage signaling in cells. Within seconds, poly(ADP-ribose)polymerase-1 (PARP-1) reacts to DNA nicks arising from oxidative damage, activating PARP-1. It signals downstream into DNA repair and cell death pathways \[[@CR1]--[@CR3]\]. PARP-1 produces large amounts of long and branched poly(ADP-ribose) molecules primarily on itself in an automodification reaction \[[@CR1], [@CR3]\]. The local polymer concentration increases several 100-fold, but decreases rapidly due to degradation by poly(ADP-ribose)glycohydrolase (PARG). PARG produces primarily ADP-ribose, albeit a few polymers may arise from endoglycosidic enzyme activity \[[@CR4], [@CR5]\].

The biological role of this dynamic poly(ADP-ribose) turnover is poorly understood. In several cell types, PARP-1 activation induces the release of apoptosis-inducing factor (AIF) from the inner mitochondrial membrane and its translocation to the nucleus, where it triggers chromatin condensation and large-scale DNA fragmentation \[[@CR6]--[@CR11]\]. AIF release involves proteolytic cleavage, either by calpain or by caspases pending on the type of cytotoxic stress and the cell type \[[@CR8], [@CR12]--[@CR14]\]. By contrast, AIF translocation apparently may proceed also in the absence of proteolytic cleavage \[[@CR15]\].

In vitro and in vivo evidence combined from different cell types indicates that poly(ADP-ribose) metabolism is involved in Ca^2+^ gating. Patch clamp experiments in lymphocytes showed that ADP-ribose addition to the inner chamber may activate a calcium channel at the outer cell membrane, termed melastatin-like transient receptor potential 2 channel (TRPM2) \[[@CR16]\]. In microglia cells, ADP-ribose added to the intracellular pipette of a whole-cell-patch clamp assay causes TRPM2-mediated Ca^2+^ currents \[[@CR17]\]. Oxidant-induced TRPM2 activation is inhibited by genetic or chemical disruption of PARP-1 activity in lymphocytes \[[@CR16]\] and in a kidney cell line overexpressing TRPM2 \[[@CR18]\].

In the present study, we used genetic knockout, RNAi, and chemical inhibitors to manipulate PARP-1, PARG, and TRPM2 to pinpoint the role of poly(ADP-ribose) metabolism in triggering calcium fluxes, caspase activation, AIF translocation, and cell death in a well-defined cell system after H~2~O~2~. We found that TRPM2 is the major channel for generating the Ca^2+^ influx after oxidative stress. Furthermore, abrogation of PARP-1 or PARG function affected the signal for TRPM2 activation, Ca^2+^ fluxes, caspase activation, AIF translocation, and cell death. The results suggest that PARG acts as the immediate upstream regulator of TRPM2 by generating ADP-ribose. Loading cells with ADP-ribose triggered a Ca^2+^ influx in the absence of oxidative damage. Thus, PARP-1 and PARG are an integral part of a cell death pathway that operates between five different cell compartments and communicates via three types of chemical messengers: a nucleotide, a cation, and proteins.

Materials and methods {#Sec2}
=====================

Cell culture {#Sec3}
------------

Immortalized mouse embryonic fibroblasts (MEFs) of *wild-type* and *parp-1*^−/−^ background were used. MEFs were cultured at 37°C in a water-saturated, 5% CO~2~/95% air atmosphere, in complete Dulbecco's modified Eagle's medium (DMEM) containing 1 g/l glucose and supplemented with 10% (v/v) FBS and antibiotics (Invitrogen).

Calcium measurements and visualization {#Sec4}
--------------------------------------

Twenty thousand cells per well in 96-well plates (Costar Corning Incorporated) were washed twice with 49 parts of calcium-free HBSS (0.49 mM MgCl~2~, 0.41 mM MgSO~4~, 5.33 mM KCl, 0.44 mM KH~2~PO~4~, 4.17 mM NaHCO~3~, 137 mM NaCl, 0.34 mM Na~2~HPO~4~, 5.56 mM dextrose) supplemented with 1 part 1 M HEPES (pH 7.2) (assay buffer) containing CaCl~2~ or not. Then, 100 μl Fluo-4-NW-dye-mix from Molecular Probes (Invitrogen) was added and incubated for 30 min at 37°C, followed by 30-min incubation in the dark at room temperature. Basic relative fluorescence units (RFU) before challenging the cells are shown in Supplementary Figures S4A, S4B. Changes in fluorescence from the Fluo-4-NW-dye quantify changes in intracellular calcium concentrations (excitation/emission 485/535 nm; slits 10/15 nm) in LS55 luminescence spectrometer (Perkin-Elmer) after H~2~O~2~. Calcium was monitored for 30 min with a measure frequency of 0.1 s. Each 50th time-point was taken for calculation. Every Fluo-4 analysis was monitored in parallel by at least one positive or negative control at each day of measurement. The statistical analysis is summarized in Supplementary Figure S4E.

For Ca^2+^ visualization, Fluo-4 loaded cells were analyzed 3 h after H~2~O~2~ treatment in a fluorescence microscope (Nikon). This time point was chosen according the offscale time in fluospectroscopic Fluo-4 analysis.

Loading of cells with ADP-ribose {#Sec5}
--------------------------------

For the Fluo-4 assays with pure ADP-ribose as a trigger for intracytosolic Ca^2+^ shifts, MEFs were loaded with monomeric ADP-ribose using the transfection reagent siPORT amine (Ambion). A total of 50 μl of 10 mM ADP-ribose in Fluo-4 assay buffer was incubated with 3 μl siPORT amine for 20 min at 37°C. Afterwards, this mixture was given on Fluo-4-loaded cells and preincubated together with cells for 25 min in a final volume of 200 μl (ADP-ribose at 2.5 mM) before intracytosolic Ca^2+^ shifts were monitored for 30 min as described above. Control experiments were performed with ADP-ribose solution without transfectant and Fluo-4 assay buffer with siPORTamine.

Chemicals {#Sec6}
---------

H~2~O~2~, *N*-(*N*-((Phenylmethoxy)carbonyl)-[l]{.smallcaps}-valyl)-phenylalaninal (MDL 28170) and ADP-ribose from SIGMA. 3-aminobenzamide (3-AB), 2-Methyl-3,5,7,8-tetrahydrothiopyranol-(4,3-d)-pyrimidine-4-one (DR2313), *N*-(6-Oxo-5,6-dihydro-phenanthridin-2-yl)-*N*,*N*-dimethylacetamide.HCl (PJ-34) from Alexis Biochemicals. 1,2-bis-(*o*-Aminophenoxy)-ethane-*N*,*N*,*N*′,*N*′-tetraaceticacid-tetraacetoxymethylester (BAPTA-AM) from Enzo Life Sciences. *N*-(*p*-Amylcinnamoyl)-anthranilicacid (ACA), *N*-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methylketone (Q-VD-OPh) from Calbiochem. 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002) was obtained from Biaffin.

Inhibitors were dissolved in DMSO. All other chemicals were from Applichem, Fluka, Merck, or SIGMA.

Viability assay {#Sec7}
---------------

Cells were seeded in 96-well plates (15,000 cells/well). H~2~O~2~ was diluted in OptiMEM and cells were treated with 50 μl/well for 1 h before 150 μl DMEM was added. After 20 h, medium was replaced with 200 μl DMEM 10% (v/v) Alamar blue (Serotec). After 4 h, fluorescence was monitored at 530-nm excitation and 590-nm emission wavelength (LS55 luminescence spectrometer, Perkin-Elmer).

Western-blot analyses and PAR immunofluorescence {#Sec8}
------------------------------------------------

The following primary antibodies were used: anti-PARP-1 (Alexis; C2-10, 1:5,000), anti-AIF (Serotec; 1:500), anti-GAPDH (Ambion; 1:1,00,000), anti-MnSOD (BD Biosciences; 1:1,000), anti-Topo-1 (BD Biosciences; 1:5,000), anti-α-tubulin (Sigma; 1:50,000), anti-PAR (Alexis; 1:1,000), anti-α-fodrin (ENZO Life Sciences; 1:8,000); anti-cleaved PARP (Asp214, 1:1,000), anti-caspase 12 (1:1,000), anti-cleaved caspase 9 (Asp353, 1:1,000), anti-cleaved caspase 6 (Asp162, 1:1,000), anti-cleaved caspase 3 (Asp175, 1:1,000), anti-caspase 9 (1:1,000), anti-caspase 6 (1:1,000), anti-caspase 3 (1:1,000), anti-phospho-PERK (Thr 980, 1:1,000, all from Cell Signaling). Anti-p-CaMKIIα (Thr 286-R, 1:1,000) and anti-CaMKII (M-176, 1:1,000) were obtained from Santa Cruz. Anti-calmodulin (1:1,000) was from Epitomics. All secondary antibodies were from Sigma. PAR detection after H~2~O~2~ exposure was performed by immunofluorescence microscopy \[[@CR7]\].

Cellular subfractionation {#Sec9}
-------------------------

This was performed as described before \[[@CR7]\]. Briefly, MEFs were harvested and washed twice with Tris--HCl (pH 7.0), 0.13 M NaCl, 5 mM KCl, 7.5 mM MgCl~2~. After incubation in 3.5 mM Tris--HCl (pH 7.8), 3 mM NaCl, 0.5 mM MgCl~2~ for 5 min, cells were mechanically broken. The homogenate was mixed with one-ninth of the cell-volume of 0.35 M Tris--HCl (pH 7.8), 0.2 M NaCl, 50 mM MgCl~2~, and spun for 3 min at 1,600 × *g*. The pellet (nuclei) was harvested directly in Laemmli buffer and the supernatant was recentrifuged under the same conditions. The final supernatant was spun at 13,000 × *g* for 1 min and the resulting mitochondrial pellet was washed once with 35 mM Tris--HCl (pH 7.8), 20 mM NaCl, 5 mM MgCl~2~, then twice with 10 mM Tris--HCl (pH 7.4), 1 mM EDTA, 0.32 M sucrose and finally resuspended in Laemmli buffer. The procedure was performed at 4°C and a protease-inhibitor-cocktail (Complete^TM^, EDTA-free, Roche) was added to all Tris-buffers.

PCR analysis {#Sec10}
------------

cDNA was produced from cells using the cells-to-cDNA II kit (Ambion) and used as templates for GAPDH and TRPM2 amplification in quantitative real-time PCR, with primers from Assays-on-demand Gene Expression products, in a reaction mixture including TaqMan Universal PCR Master Mix (Applied Biosystems). Real-time PCR experiments were carried out on an ABI PRISM 7700 cycler (95°C, 15 s; 60°C, 1 min; 40 cycles). For quantification, ΔΔC~t~ method was used. The TRPM2 primers were 5′-TACACTGACAGGCCACGGCT-3′ and 5′-CCAGCATGCACAGGATGATC-3′ (Microsynth). PCR analysis was performed in a reaction mixture including TaqMan Mix (Sigma) on Touchgene machine (TECHNE; 95°C, 5 min initial denaturation; 30 cycles of denaturation (95°C, 30 s), annealing (54°C, 30 s) and elongation (72°C, 1 min); 5 min of final extension at 70°C).

RNA interference {#Sec11}
----------------

Poly(ADP-ribose)polymerase-1 targeting template sequences (siRNA-P1): 5′-AAACAGTAATAAGCGTCGCTCCCTTC-3′ (sense) and 5′-AAGAGCGACGCTTATTACTGTCCTGTCTC-3′ (antisense) \[[@CR7]\]. The PARG targeting siRNA (siRNA-G) has been described earlier (Microsynth) \[[@CR7], [@CR19]\]. The siRNA against TRPM2 (siRNA-T2) was obtained from Applied Biosystems; 5′-GAGUCUACGUGGUCGAGUATT-3′ (sense) and 5′-UACUCGACCACGUAGACUCCA-3′ (antisense). All transfection experiments were performed with siPORT amine (Ambion) as transfection reagent under conditions described earlier \[[@CR19]\].

NAD^+^ determination {#Sec12}
--------------------

Measurement of NAD^+^ was according to Jacobson and Jacobson \[[@CR20]\]. Cells were in 96-well plates (25,000 cells/well). After treatment with 5 mM H~2~O~2~ in OptiMEM (50 μl/well), the cells were lysed with 50 μl ethanol supplemented with isonicotinic acid-hydrazide (20 mM, for 30 min at −80°C) at 10, 20, and 30 min. The assay volume of 300 μl/well contained 570 mM ethanol, 114 mM bicine pH 7.8, 4.8 mM EDTA and 1 mg/ml BSA. The color change of thiazolyl-blue-tetrazolium-bromide (MTT, 0.48 mM, SIGMA) was measured 15 min after ADH was added (6 μg/ml, Roche) in a UV spectrometer (Bio-Rad) at 570 nm. A calibration curve was performed in parallel.

Statistical analysis {#Sec13}
--------------------

Results are shown as mean ± SD of at least three independent experiments. The significance of differences was estimated by ANOVA followed by the method of Kolmogorov and Smirnov. *p* \< 0.05 was considered significant. All statistical analyses were performed with InStat3 software (GraphPad Software).

Results {#Sec14}
=======

Oxidative stress induces PAR formation, Ca^2+^ fluxes, and cell death {#Sec15}
---------------------------------------------------------------------

Cell death induced by H~2~O~2~ is preceded by PAR formation and Ca^2+^ fluxes in mouse embryonic fibroblasts (MEFs) (Fig. [1](#Fig1){ref-type="fig"}). Cell death was dose-dependent (Fig. [1](#Fig1){ref-type="fig"}a), reducing viable cells by 29.8 ± 7.4% at 0.5 mM and 68.5 ± 4.1% at 5 mM H~2~O~2~ within 20 h. PAR induction (Fig. [1](#Fig1){ref-type="fig"}b, c) and Ca^2+^ gating into the cytosol (Fig. [1](#Fig1){ref-type="fig"}d--f) were observed within min of oxidative insults. All cytosolic Ca^2+^ could be completely quenched by a pretreatment with the Ca^2+^ chelator BAPTA (Suppl. Fig. S1A) as tested with the Fluo-4 assay. Figure [1](#Fig1){ref-type="fig"}d shows the effects of 0.5 and 5 mM H~2~O~2~ on intracellular Ca^2+^ levels over 30 min. Figure [1](#Fig1){ref-type="fig"}e shows the impact of 5 mM H~2~O~2,~ performed in presence or absence of 1 mM exogenous Ca^2+^. Moreover, 5 mM exogenous Ca^2+^ could not further promote the level of Ca^2+^ signals obtained with 1 mM Ca^2+^ (Suppl. Fig. S1D). Cytosolic Ca^2+^ also increased in the absence of exogenous Ca^2+^, suggesting that Ca^2+^ was released from endogenous Ca^2+^ stores. Ca^2+^-free conditions did not affect cell viability or baseline Ca^2+^ levels (Suppl. Fig. S1B, S1C). Figure [1](#Fig1){ref-type="fig"}f shows a comparison of Ca^2+^ from internal and external sources. Low levels of H~2~O~2~ (0.5 mM) cause exclusively Ca^2+^ influxes from the extracellular milieu, rising continuously up to 30 min. High levels of H~2~O~2~ (5 mM) lead to Ca^2+^ shifts from extra- and intracellular sources, producing a peak at 150 s, a trough at 650 s, followed by a continuous rise of Ca^2+^ (Fig. [1](#Fig1){ref-type="fig"}d--f). Compared to other cell organelles, the basal Ca^2+^ concentration of endoplasmic reticulum is 5,000-fold higher than cytosolic Ca^2+^, and hence is the most likely source of intracellular Ca^2+^ releases \[[@CR21]\]. However, the Ca^2+^ peak at 150 s could be addressed to PI3K (phosphoinositide 3-kinase) activity as it could be reduced by the parallel incubation with its inhibitor LY294002 (50 μM, data not shown).Fig. 1Effects of H~2~O~2~ on poly(ADP-ribose), Ca^2+^ levels, and cell survival. **a***Wild-type* MEFs were treated with 0.5 or 5 mM of H~2~O~2~ for 20 h. Cell survival was monitored by Alamar blue assay. Results represent the mean ± SD for at least three independent experiments (^\#^*p* \< 0.0025; \**p* \< 0.0001; *t* test). **b** Western-blot analysis of PAR after 15 min of H~2~O~2~ treatment. GAPDH is loading control. **c** PAR detection by immunofluorescence after 30 min of H~2~O~2~ treatment. HOECHST staining is also shown. **d** Fluo-4 assay of H~2~O~2~-challenged cells. Changes of cytosolic Ca^2+^ were monitored directly after treatment for 30 min by fluorescence spectrometry and are expressed as ΔRFU compared to basic levels. Results represent mean ± SD (^\#^*p* \< 0.005; \**p* \< 0.0001; *n* = 4; *t* test). **e** Ca^2+^ determination after 5 mM H~2~O~2~ with and without extracellular Ca^2+^ ions. Shown are ΔRFUs and *error bars* (^\#^*p* \< 0.025; \**p* \< 0.001; *n* = 4; *t* test). **f** Comparison of Ca^2+^ from intra- and extracellular sources after 0.5 or 5 mM of H~2~O~2~. Shown are ΔRFUs with or without Ca^2+^ in the buffer at characteristic time points (150, 650, and 1,700 s; *n* = 4)

PARP-1 inhibition by chemicals, RNAi and knockout reduce H~2~O~2~ cytotoxicity and cytosolic Ca^2+^ shifts {#Sec16}
----------------------------------------------------------------------------------------------------------

Using chemical inhibition, RNAi silencing or genetic knockout of *parp-1*, we determined the consequences on cytosolic Ca^2+^ shifts and cell survival (Fig. [2](#Fig2){ref-type="fig"}). Regardless of the type of PARP-1 abrogation, H~2~O~2~-induced cytotoxicity (Fig. [2](#Fig2){ref-type="fig"}a) and cytosolic Ca^2+^ increases (Fig. [2](#Fig2){ref-type="fig"}b--g) were reduced. In particular, PARP inhibitor 3-aminobenzamide (3-AB) decreased cytosolic Ca^2+^ shifts up to 30 min (Fig. [2](#Fig2){ref-type="fig"}b), and this was observed over a dose range of 1--10 mM (Suppl. Fig. S2C). Inhibition of PARP reduced Ca^2+^ levels after H~2~O~2~ (Fig. [2](#Fig2){ref-type="fig"}c). 3-AB was not toxic per se nor did it affect the expression of PARP-1 (Suppl. Fig. S2A, S2B). Moreover, the presence or absence of Ca^2+^ did not alter the baseline levels (Suppl. Figs. S2D, S2E, S4A). These results were confirmed with other PARP inhibitors: cells grown in the presence of 5 μM PJ-34 (Fig. [2](#Fig2){ref-type="fig"}d; Suppl. Fig. S4A) or 100 μM DR2313 (Fig. [2](#Fig2){ref-type="fig"}e; Suppl. Fig. S4A) showed similar Ca^2+^ shifts after H~2~O~2~ as those grown in 3 mM 3-AB (Fig. [2](#Fig2){ref-type="fig"}b).Fig. 2Inhibition of PARP-1 protects cells against cytotoxicity and reduces Ca^2+^ levels after H~2~O~2~. **a***Wild-type* (wt P1), *parp-1*^−/−^ MEFs (P1^−/−^) and cells incubated with 3 mM 3-AB overnight (3-AB) or silenced for the *parp-1* gene (siRNA-P1) were challenged with 5 mM H~2~O~2~. After 20 h, cytotoxicity was determined by Alamar blue assay (mean ± SD; ^\#^*p* \< 0.025; \**p* \< 0.0025; *n* ≥ 3; *t* test). **b** Ca^2+^ assays of *wild-type* (wt P1) and 3-AB (3 mM) treated cells. MEFs were monitored for Ca^2+^ alterations after 5 mM H~2~O~2~ (mean ± SD; *n* ≥ 4). **c** Differences in cytosolic Ca^2+^ levels after 5 mM H~2~O~2~ in *wild-type* (wt P1), 3-AB (3 mM) treated cells and MEFs silenced with siRNA against *parp-1* (siRNA-P1) as well as cells transfected with a control siRNA (siRNA-C) after 1,700 s (mean ± SD; \**p* \< 0.025; *n* ≥ 3; *t* test). **d** Ca^2+^ assays of *wild-type* cells (wt P1) and cells with 5 μM of PARP-inhibitor PJ-34 (wt P1 + PJ-34) after 5 mM H~2~O~2~ (mean ± SD; *n* ≥ 4). Values of controls (wt P1 + PJ-34 untreated) are shown too (mean ± SD; *n* = 2). **e** Effect of PARP-inhibitor DR2313 (100 μM) on Ca^2+^ shifts after 5 mM H~2~O~2~ (mean ± SD; *n* ≥ 3). Ca^2+^ values of controls (wt P1 + DR2313 untreated) are presented (*n* = 1). **f** MEFs were silenced for the *parp-1* gene (siRNA-P1) and subjected to Fluo-4 assay. Cells treated with a control RNA sequence (siRNA-C) were analyzed in parallel. Shown are the mean ± SD (*n* = 4). Silencing efficacy was determined by Western blot with GAPDH as loading control. **g** Comparison of Ca^2+^ levels from intra- and extracellular sources after 5 mM H~2~O~2~ in *wild-type* (wt P1) and *parp-1*^−/−^ (P1^−/−^). Shown are ΔRFUs (mean ± SD; *n* ≥ 4) of Ca^2+^ assays with or without Ca^2+^ in the buffer as indicated at 1,700 s after treatment. Western-blot analysis for PARP-1 protein is shown too with α-tubulin as loading control

As expected, RNAi silencing of *parp-1* reduced PARP-1 protein to very low levels (Fig. [2](#Fig2){ref-type="fig"}f, Western blot) and caused a further reduction of Ca^2+^ signals from extracellular space after an oxidative insult (Fig. [2](#Fig2){ref-type="fig"}c, f). Using a third approach, we determined Ca^2+^ shifts in *parp-1*^−/−^ cells (Fig. [2](#Fig2){ref-type="fig"}g, [3](#Fig3){ref-type="fig"}a). The *parp-1* gene knockout was verified by Western blot (Fig. [2](#Fig2){ref-type="fig"}g) and the inability to convert NAD^+^ into PAR after H~2~O~2~ (Suppl. Fig. S2G). The reduction of the basal NAD^+^ content in *parp-1*^−/−^ cells challenged with 5 mM H~2~O~2~ is likely due to PARP-2 activity \[[@CR33]--[@CR35]\]. Evidently, MEFs lacking PARP-1 are resistant to H~2~O~2~-induced cytotoxicity (Fig. [2](#Fig2){ref-type="fig"}a) and did not show any Ca^2+^ influx from the extracellular space (Fig. [2](#Fig2){ref-type="fig"}g; Suppl. Figs. S2F, S2H, S2I, S4A).Fig. 3Effects of H~2~O~2~ on cytosolic Ca^2+^ and Ca^2+^ signaling. **a** Microscopic visualization of intracellular Ca^2+^ shifts after 5 mM H~2~O~2~ (3 h) using the Ca^2+^ indicator Fluo-4 in *wild-type* and *parp-1*^−/−^ cells. **b** Western-blot analysis of phosphorylated PERK protein with α-tubulin as loading control. *Wild-type* (wt P1) and *parp-1* knockout MEFs (P1^−/−^) were treated for the indicated timepoints with 5 mM H~2~O~2~. **c** Western-blot analysis of phosphorylated CaMKII in H~2~O~2~ (5 mM) treated *wild-type* (wt P1) and *parp-1*^−/−^ MEFs (P1^−/−^) at the indicated timepoints. CaMKII is shown as a loading control. **d** Western-blot analysis of α-fodrin in *wild-type* (wt P1) and *parp-1* knockout (P1^−/−^) cells. Cells were treated with 5 mM H~2~O~2~ for the indicated time points, harvested and subjected to Western-blot analysis. GAPDH is loading control. **e** Activation of caspases and appearance of cleaved PARP-1 after 5 mM H~2~O~2~ is shown in Western-blot analysis of whole cell lysates prepared from *wild-type* (wt P1) and *parp-1* knockout (P1^−/−^) cells at the indicated timepoints. GAPDH and α-tubulin are shown as loading controls. **f** Translocation of AIF after H~2~O~2~ insult was determined in *wild-type* cells silenced for the *parp-1* gene by RNAi (siRNA 1) and cells silenced with a scrambled control siRNA (siRNA C). After 6 h treatment with 5 mM H~2~O~2~, cells were subjected to subcellular fractionation and immunoblotting. Topo-1 and MnSOD protein are also shown

To further address the role of PARP-1 in Ca^2+^ signaling, Ca^2+^ levels were visualized in *parp-1*^−/−^ versus *wild-type* cells by fluorescence microscopy after 5 mM H~2~O~2~ (Fig. [3](#Fig3){ref-type="fig"}a). While detectable Ca^2+^ levels were seen in *wild-type* cells, *parp-1*^−/−^ failed to show a signal. The amount of cytosolic Ca^2+^ after H~2~O~2~ is of biological relevance because the Ca^2+^/calmodulin dependent protein kinase II (CaMKII) becomes phosphorylated only in *wild-type* cells (Fig. [3](#Fig3){ref-type="fig"}c). The expression level of calmodulin is similar in *wild-type* and *parp-1*^−/−^ cells (Suppl. Fig. S3A). Interestingly, the marginal PARP-1-independent Ca^2+^ released from intracellular sources displays endoplasmic reticulum stress as assayed by the phosphorylation of protein kinase-like endoplasmic reticulum kinase \[[@CR22]\] (PERK, Fig. [3](#Fig3){ref-type="fig"}b). Our findings suggest that PARP-1 activity is required for the influx of Ca^2+^ from the extracellular space leading to Ca^2+^ signaling after an oxidative insult.

PARP-1-dependent Ca^2+^ gating initiates downstream factors in cell death {#Sec17}
-------------------------------------------------------------------------

We next determined the PARP-1 dependency of extracellular Ca^2+^ influxes on the activation of calpain and caspases, which is a controversial issue in AIF release \[[@CR8], [@CR12]--[@CR15], [@CR23]--[@CR25]\]. A total of 5 mM H~2~O~2~ induced activation of calpain as determined by α-fodrin cleavage \[[@CR14]\]. However, this activation was independent of PARP-1 (Fig. [3](#Fig3){ref-type="fig"}d). By contrast, the activation of caspases 3, 6, and 9 was clearly reduced in *parp-1*^−/−^ cells (Fig. [3](#Fig3){ref-type="fig"}e), some of them being implicated in AIF release from the inner mitochondrial membrane \[[@CR7], [@CR12], [@CR14]\]. Caspase 12 activation was identical in PARP-1-proficient and -deficient cells (Fig. [3](#Fig3){ref-type="fig"}e), which is in line with results of Fig. [3](#Fig3){ref-type="fig"}d and the literature demonstrating intracellular Ca^2+^ currents and calpain induction in various cell-death models connected with stress to endoplasmic reticulum \[[@CR26]--[@CR28]\]. The expression levels of caspases were identical in *wild-type* and *parp-1*^−/−^ cells (Suppl. Fig. S3C). A parallel inhibition of calpains (MDL 28170) or caspases (Q-VD-OPh) could reduce the specific proteolytic truncates (Suppl. Fig. S3B, S3D). Hence we conclude that the PARP-1 independent intracellular Ca^2+^ shifts are sufficient for calpain activation and that the activation of caspases requires PARP-1.

The next series of experiments examined AIF translocation in cells silenced for *parp-1*. While AIF migrates from mitochondria to the nucleus in H~2~O~2~-challenged control cells (siRNA C), the translocation was inhibited in cells silenced for PARP-1 (siRNA 1, Fig. [3](#Fig3){ref-type="fig"}f). As a final consequence, cells with an impaired PARP-1 system showed an increased survival rate after an oxidative challenge (Fig. [2](#Fig2){ref-type="fig"}a).

TRPM2 is the primary channel for PARP-1-dependent extracellular Ca^2+^ gating {#Sec18}
-----------------------------------------------------------------------------

In order to determine the type of channel involved in Ca^2+^ gating, RNAi experiments were performed. RNAi silencing of TRPM2 channel reduced Ca^2+^ to the levels resistant to PARP-1/PARG regulation (Fig. [4](#Fig4){ref-type="fig"}a; Suppl. Figs. S2N, S4B), suggesting a primary role of this channel in death signaling. Likewise, *N*-(*p*-Amylcinnamoyl)anthranilic acid (ACA), a broad spectrum TRP channel blocker with an IC~50~ of 1.7 μM for TRPM2 \[[@CR29]--[@CR31]\], confirmed this finding (Fig. [4](#Fig4){ref-type="fig"}b; Suppl. Fig. S4A). Thus, TRPM2 seems to account for the extracellular Ca^2+^ transients in cells exposed to 5 mM H~2~O~2~. We then examined the possibility that PARP-1 could affect the expression levels of TRPM2 in MEFs. Supplementary Figure S2L and S2M show that TRPM2 expression was identical in *wild-type* and *parp-1*^−/−^ MEFs as determined by RT-PCR and endpoint PCR analysis.Fig. 4PARG and TRPM2 are required for Ca^2+^ gating. **a** Fluo-4 assay in cells silenced (siRNA-T2) or unsilenced (siRNA-C) for the *trpm2* gene after 5 mM H~2~O~2~ (mean ± SD; *n* = 3). **b** Differences in extracellular Ca^2+^ entry after 5 mM H~2~O~2~ in control and ACA-treated cells (5 μM ACA with additional pretreatment of ACA for 5 min) after 1,700 s (mean ± SD; *n* ≥ 4; \**p* \< 0.001; *t* test). **c** MEFs were silenced for the *parg* gene (siRNA-G) and subjected to Fluo-4 assay. Cells treated with a control RNA sequence (siRNA-C) were analyzed in parallel. Shown are the mean ± SD (*n* ≥ 3). **d** Western-blot analysis of AIF translocation from mitochondrial to the nuclear fraction. Control (siRNA-C) and *parg* silenced cells (siRNA-G) treated with 5 mM H~2~O~2~ or solvent controls were subjected to subcellular fractionation at 6 h. Topo-1 and MnSOD served as loading and fraction purity controls. **e** Control MEFs (siRNA-C) and *parg*-silenced cells (siRNA-G) were challenged with 5 mM H~2~O~2~. After 20 h, survival rates were determined by Alamar blue dye. Shown are the results as percent of the untreated control cells (mean ± SD; \**p* \< 0.005; *n* = 3; *t* test). **f** MEFs were loaded with ADP-ribose (2.5 mM ADP-ribose in assay buffer + transfectant) before subjected to the Fluo-4 assay (mean ± SD; *n* = 3). ADP-ribose (2.5 mM) without transfectant was used as a control (mean ± SD; *n* = 3). **g** Control (siRNA-C) and *trpm2*-silenced cells (siRNA-T2) were loaded with ADP-ribose (2.5 mM ADP-ribose in assay buffer + transfectant) before subjected to the Fluo-4 assay (mean ± SD; *n* = 2). **h** Western-blot analysis of AIF translocation from mitochondrial to the nuclear fraction. Control (siRNA-C) and *trpm2*-silenced cells (siRNA-T2) treated with 5 mM H~2~O~2~ or solvent controls were subjected to subcellular fractionation at 6 h. Topo-1 and MnSOD served as loading controls

PARG generates ADP-ribose, the signal for TRPM2 activation and downstream events in oxidant-induced cell death {#Sec19}
--------------------------------------------------------------------------------------------------------------

We next hypothesized that PARG could control Ca^2+^ shifts by converting poly(ADP-ribose) into ADP-ribose, a possible activator of TRPM2 channels in vitro. First, we analyzed Ca^2+^ in MEFs with a silenced *parg* gene (siRNA-G) after 5 mM H~2~O~2~ and compared them with cells transfected with control siRNA (siRNA-C, Fig. [4](#Fig4){ref-type="fig"}c; Suppl. Figs. S2J, S2K, S4B). We published earlier that *parg* silencing is characterized by a reduced level of *parg* mRNA, PARG protein as well as enzymatic activity and results in a transient accumulation of long PAR molecules after oxidative stress \[[@CR19]\]. Ca^2+^ shifts obtained in *parg* silenced cells were similar to those previously described in cells with abrogated TRPM2 (Fig. [4](#Fig4){ref-type="fig"}a) or PARP-1 function (Fig. [2](#Fig2){ref-type="fig"}b--g). Thus, PARG is the major regulator of TRPM2-mediated Ca^2+^ fluxes in cells subjected to oxidative stress. As expected, the reduced Ca^2+^ shifts resulted in an impaired AIF translocation from mitochondria to nucleus (Fig. [4](#Fig4){ref-type="fig"}d) and in a reduced cytotoxicity after 5 mM (Fig. [4](#Fig4){ref-type="fig"}e). To directly demonstrate the role of ADP-ribose as TRPM2 activator, cells were loaded with the nucleoside and intracellular Ca^2+^ levels monitored (Fig. [4](#Fig4){ref-type="fig"}f). The results show that ADP-ribose per se can cause a rise in cytosolic Ca^2+^ in the complete absence of oxidative stress. This effect is not seen when ADP-ribose was added in the absence of transfection agent or with transfection agent and assay buffer (Suppl. Fig. S4D). In fact, when MEFs were silenced for the *trpm2* gene, transfected ADP-ribose could not generate a cytosolic Ca^2+^ shift (Fig. [4](#Fig4){ref-type="fig"}g), indicating an important role of TRPM2 in Ca^2+^ gating through intracellular ADP-ribose as second messenger. Moreover, the translocation of AIF after oxidative stress was impaired after silencing of *trpm2* (Fig. [4](#Fig4){ref-type="fig"}h). Interestingly, RNAi against *trpm2* could not rescue the cells from cell death (data not shown), suggesting the involvement of an AIF-independent branch of the cell death pathway, as has been reported \[[@CR57]\].

Discussion {#Sec20}
==========

Cell death following oxidative stress involves diverse 'death signals'. It is not clear how these signals cooperate between several cell compartments to trigger cell death in a specific cell type \[[@CR2], [@CR28], [@CR32]\]. Our results link PARP-1 and PARG activity, TRPM2-gated Ca^2+^, and caspase activation with AIF translocation and cell death. Figure [5](#Fig5){ref-type="fig"} assembles the signaling elements into a schematic pathway. The first step is the generation of DNA damage by oxidative stress (H~2~O~2~). This activates PARP-1 generating a burst of PAR synthesis, a Ca^2+^ influx and cell death (Fig. [1](#Fig1){ref-type="fig"}). Besides PARP-1, PARP-2 has been shown to be stimulated by genotoxins in vitro and in vivo \[[@CR33]--[@CR35]\]. However, PARP-1 is the main enzyme producing PAR, accounting for \>99% of PAR in cells after genotoxic insults \[[@CR36]--[@CR38]\]. Our results demonstrate that regardless of the method of PARP-1 abrogation, the Ca^2+^ influx and cell death was reduced (Fig. [2](#Fig2){ref-type="fig"}). Likewise, caspase activation and AIF translocation from mitochondria to the nucleus was suppressed (Fig. [3](#Fig3){ref-type="fig"}). Importantly, RNAi against TRPM2 or PARG blocked the Ca^2+^ influx suggesting that TRPM2 was the primary Ca^2+^ channel for cell death signaling under PARG control. PARG-silencing also prevented AIF translocation and cell death (Fig. [4](#Fig4){ref-type="fig"}). Finally, cells loaded with ADP-ribose, the enzymatic product of PARG activity, showed a distinct Ca^2+^ influx even in the absence of oxidative damage (Fig. [4](#Fig4){ref-type="fig"}f). We conclude that PARG acts as the immediate upstream regulator of TRPM2 by generating ADP-ribose. This is compatible with patch-clamp experiments showing activation of TRPM2 when ADP-ribose was included in the intracellular pipette \[[@CR16], [@CR39]\].Fig. 5PARP-1 and PARG control TRPM2 in a multicompartment pathway to cell death. Oxidative DNA damage activates PARP-1, which converts NAD^+^ into PAR. PARG degrades PAR and produces free ADP-ribose monomers, which are released into the cytosol. There they activate intermembrane TRPM2 channels and induce a Ca^2+^ influx. Ca^2+^ activates calpains and subsequently caspases, but only the latter depends on PARP-1. Caspases become activated as a cascade (9 → 6 → 3) cleaving mitochondrial AIF, which then translocates to the nucleus to cause DNA fragmentation, chromatin condensation, and cell death

TRPM2 contains a NUDIX box sequence motif in the C-terminal domain with a binding site for ADP-ribose. The EC~50~ for ADP-ribose is 90 μM \[[@CR40], [@CR41]\], which is slightly above the intracellular ADP-ribose concentration (in the range of 5 and 90 μM) \[[@CR42], [@CR43]\]. Thus, TRPM2 gating is very sensitive to changes in intracellular ADP-ribose concentrations due to oxidant-induced stimulation of PARP-1 and PARG activity. In fact, when TRPM2 is silenced or inhibited, the gating activity for extracellular Ca^2+^ is abolished (Fig. [4](#Fig4){ref-type="fig"}a, b). Accordingly, both the level and the rate of Ca^2+^ increase depended on the dose of H~2~O~2~ (Fig. [1](#Fig1){ref-type="fig"}d). The resulting Ca^2+^ influx from the extracellular milieu (\~1 mM Ca^2+^) merges with the low concentration of the cytosolic pool (\~100 nM Ca^2+^) \[[@CR21]\], which is in the detection range of the Ca^2+^ probe Fluo-4 (*K*~D~ for Ca^2+^ 345 nM) \[[@CR44]\] used in this study. A low dose of H~2~O~2~ is sufficient to induce extracellular Ca^2+^ shifts (Fig. [1](#Fig1){ref-type="fig"}f). Nevertheless, we detected an additional Ca^2+^ shift from intracellular stores in cells treated with high doses of H~2~O~2~ (Fig. [1](#Fig1){ref-type="fig"}e, f; Suppl. Fig. S4C). The trough after the initial rise (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [4](#Fig4){ref-type="fig"}) could reflect the Ca^2+^ reuptake into intracellular Ca^2+^ stores \[[@CR21]\]. Release of Ca^2+^ from intracellular Ca^2+^ depots has been reported in pancreatic acinar cells \[[@CR45]\], neutrophils \[[@CR46]\], hepatocytes \[[@CR47]\], and in LPS-challenged microglia \[[@CR17]\] cells after H~2~O~2~.

An elevated intracellular Ca^2+^ level was shown in relationship with two types of cell death proteases involved in AIF processing and translocation from the mitochondria to the nucleus: calpain \[[@CR8], [@CR13], [@CR23], [@CR24]\] and caspases \[[@CR12], [@CR14], [@CR25]\]. Both types were activated (Fig. [3](#Fig3){ref-type="fig"}) but only the activation of caspases 3, 6, and 9---not 12---was PARP-1-dependent (Fig. [3](#Fig3){ref-type="fig"}e). Since AIF translocation from mitochondria to the nucleus was strictly PARP-1-dependent (Fig. [3](#Fig3){ref-type="fig"}f), we conclude that Ca^2+^ induces a signaling pathway leading to the consecutive activation of caspases 9, 6, and 3 (Fig. [3](#Fig3){ref-type="fig"}e) and this in turn releases AIF from the inner mitochondrial membrane to translocate to the nucleus (Fig. [3](#Fig3){ref-type="fig"}f) and to induce cell death. By contrast, calpain activation by H~2~O~2~-induced Ca^2+^ fluxes is not dependent on PARP-1 (Fig. [3](#Fig3){ref-type="fig"}d). Consistent with our observations, the PARP-1 dependency of AIF translocation has been demonstrated in other cells, but attributed to the action of polymeric and not monomeric ADP-ribose \[[@CR6], [@CR7], [@CR10]\]. Accordingly, *parg* silencing prevented AIF translocation and cell death as well (Fig. [4](#Fig4){ref-type="fig"}d, e). This may explain why PARG inhibition or genetic disruption has a cytoprotective effect in various cell types \[[@CR19], [@CR48]--[@CR50]\].

The H~2~O~2~-induced Ca^2+^ influx has been described before in cells overexpressing the TRPM2 channel \[[@CR16], [@CR41], [@CR51]\] as well as in *trpm2*^−/−^ cells restored with TRPM2 \[[@CR52]\]. Beside H~2~O~2~, cytoplasmic Ca^2+^ and ADP-ribose act as coactivators of TRPM2 gating \[[@CR17], [@CR40], [@CR41], [@CR53]\]. ADP-ribose may be converted into AMP by pyrophosphatase activity of the NUDT9 domain and thereby initiate Ca^2+^ gating via TRPM2 \[[@CR40], [@CR54]\]. Formentini et al. \[[@CR55]\] recently described a functional role for NUDIX hydrolases after PARP-1 hyperactivation, resulting in accumulation of AMP. However, enhancing the enzymatic activity of the NUDIX box abolishes ADP-ribose gating of TRPM2, confirming that ADP-ribose itself, and not its degradation product, is involved in TRPM2 gating (reviewed by Hecquet et al. \[[@CR56]\]).

Some of our observations seem to be in contrast to published results. Calpain has been implicated in AIF cleavage prior to its release from the inner mitochondrial membrane. While we could confirm calpain activation in H~2~O~2~-treated MEFs, which was inhibited by calpain inhibitor MDL 28170, it was unaffected by deletion of the *parp-1*^−/−^ gene (Fig. [3](#Fig3){ref-type="fig"}d; Suppl. Fig. S3B). The discrepancy could be explained by differences in cell death inducers, i.e., an alkylating agent \[[@CR8]\] versus H~2~O~2~ (this study), and hence differences in cell death signaling. Moreover, a recent report confirms that calpain is not required for PARP-1- and AIF-dependent cell death \[[@CR25]\]. Likewise, PARP-1-dependent cell death may also progress in an AIF-independent manner as shown by Tang et al. \[[@CR57]\] in cells deficient in base excision repair. More studies are needed to understand the complexity of molecular interactions of PAR in cell death.

We conclude that the two major PAR metabolizing enzymes PARP-1 and PARG control a cell death pathway that operates between five different cell compartments and communicates via three types of chemical messengers: a nucleotide, a cation, and proteins. PARP-1 is producing the upstream death signal poly(ADP-ribose), which is converted by PARG into ADP-ribose, to specifically activate TRPM2 with concomitant cytosolic Ca^2+^ shifts that trigger caspases, AIF translocation, and cell death.
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